ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,638.94
2.13%
US Tech 100
19,145.60
2.20%
Dow Jones
41,488.19
1.65%
Brent Oil
70.285
0.51%
Bitcoin
84,471.46
4.24%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. TNF Pharmaceuticals Inc (TNFA)

  7. TNF Pharmaceuticals Inc (TNFA) News

TNFA

TNF Pharmaceuticals (TNFA)

TNF Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TNFA
DateTimeSourceHeadlineSymbolCompany
03/10/20255:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNFATNF Pharmaceuticals Inc
02/25/20259:20AMBusiness WireTNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha InhibitorNASDAQ:TNFATNF Pharmaceuticals Inc
01/29/20259:15AMBusiness WireTNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss TreatmentNASDAQ:TNFATNF Pharmaceuticals Inc
01/15/20259:15AMBusiness WireTNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial ExpansionNASDAQ:TNFATNF Pharmaceuticals Inc
12/19/20249:15AMBusiness WireTNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss DrugsNASDAQ:TNFATNF Pharmaceuticals Inc
12/10/20248:20AMAllPennyStocks.comPremarket Action Is Heating Up For This BiotechNASDAQ:TNFATNF Pharmaceuticals Inc
12/09/20249:00AMBusiness WireTNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International ConferenceNASDAQ:TNFATNF Pharmaceuticals Inc
11/26/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNFATNF Pharmaceuticals Inc
11/14/20245:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNFATNF Pharmaceuticals Inc
11/14/20242:24PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNFATNF Pharmaceuticals Inc
11/01/20244:31PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TNFATNF Pharmaceuticals Inc
11/01/20244:30PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TNFATNF Pharmaceuticals Inc
10/04/20245:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNFATNF Pharmaceuticals Inc
10/02/20249:10AMBusiness WireTNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to MarketNASDAQ:TNFATNF Pharmaceuticals Inc
09/23/20244:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNFATNF Pharmaceuticals Inc
08/21/20249:00AMBusiness WireTNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related DeclineNASDAQ:TNFATNF Pharmaceuticals Inc
08/19/20246:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNFATNF Pharmaceuticals Inc
08/14/20244:33PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TNFATNF Pharmaceuticals Inc
08/14/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNFATNF Pharmaceuticals Inc
08/13/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TNFATNF Pharmaceuticals Inc
08/12/20245:10PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TNFATNF Pharmaceuticals Inc
08/08/20245:13PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TNFATNF Pharmaceuticals Inc
07/26/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNFATNF Pharmaceuticals Inc
07/26/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNFATNF Pharmaceuticals Inc
07/24/20249:05AMBusiness WireTNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open TodayNASDAQ:TNFATNF Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TNFA

Your Recent History

NASDAQ
WBD
Warner Brothers Discovery
NASDAQ
EBC
Eastern Bankshares
NYSE
HESM
Hess Midstream
NYSE
TRNO
Terreno Realty
NYSE
RVTY
Revvity
AMEX
ITOT
S&P Total US Stock Market
AMEX
STCE
Schwab Crypto Thematic ETF
AMEX
IVVW
iShares S&P 500 BuyWrite...
TSXV
PGO.H
Pacific GeoInfo
NASDAQI
OMXNLCDKKPI
OMX Nordic Large Cap DKK...
NASDAQ
AAL
American Airlines
BOV
ENEV3M
ENEVA ON
NASDAQ
HQY
HealthEquity
AMEX
USMF
WisdomTree US Multifactor
NYSE
PSQH
PSQ
NASDAQ
FNK
First Trust Mid Cap Valu...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads